EDMONTON, Alberta – (November 2, 2016) – NanoSpeed Diagnostics Inc. (“NanoSpeed” or “the Company”) is pleased to announce that it was chosen to be a finalist in the category of Advanced Technology and Innovation by the Alberta Export Awards presented by Edmonton Economic Development Corporation and the Edmonton International Airport.
The Company’s Test4D™ product is currently being sold through distributors globally based in Europe, China, India and the Philippines.
The Alberta Export Awards are the province’s most prestigious awards, paying tribute to the success and innovative approaches of Alberta export companies. Extending across industries and including both rural and urban representation, the awards are a celebration of the contributions exporters have made to both the provincial and national economy.
Winners of each of the categories will be announced at the gala luncheon on December 8, 2016 at the Renaissance Hotel in Edmonton, Alberta. This event attracts top exporters in the Alberta community and provides an invaluable opportunity for networking. To register for the 2016 Alberta Export Awards gala luncheon please visit http://www.albertaexportawards.com/registration-information/
About NanoSpeed Diagnostics Inc.
NanoSpeed, incorporated in 2009, develops proprietary diagnostic/screening test kit platforms based on their Lateral Flow Immuno Assay and Lab-on-a-Chip technologies. NanoSpeed is located at the Advanced Technology Centre at the Edmonton Research Park in Edmonton, Alberta. These technological advancements provide patients with cost-effective and reliable testing tools that will address the increasing needs of the healthcare industry, regulatory agencies and consumers. For more information please visit: www.nanospeed.ca
About Vitamin D deficiency and Test4D™
Vitamin D deficiency is a common problem in Canada, where 60% of adults have suboptimal levels of 25-OH vitamin D. Vitamin D deficiency has been associated with abnormalities in absorption of calcium, phosphorus, and bone metabolism; cardiovascular disease; diabetes; cancer; osteomalacia and osteoporosis in adults; and rickets in children. Deficient vitamin D levels are typically the result of an inadequate intake of vitamin D through sunlight, diet, or supplements, or due to malabsorptive disorders.
25-OH vitamin D levels are currently measured through laboratory testing. Over the past decade, there has been an incremental surge in the demand for vitamin D testing, resulting in increasing costs to government supported healthcare systems. An alternative to laboratory testing is Point-of-Care-Testing (POCT), medical testing that occurs outside of a clinical laboratory and near the patient. Potential advantages of POCT include reduction in errors and costs to the healthcare system, and the provision of quick clinical diagnoses.
To address the demands of vitamin D testing, NanoSpeed Diagnostics Inc. developed Test4D™, a POCT device for the qualitative detection of 25-OH Vitamin D in human blood obtained via fingertip puncture.
Test4D™ is available for commercial sale through certain distributors, or can be purchased for research purposes directly from NanoSpeed.